Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Another Class I Correction Needed On Baxter Infusion Pumps

This article was originally published in The Gray Sheet

Executive Summary

A recall initiated last month by Baxter removing 4,500 upgraded versions of its triple-channel Colleague infusion pumps from use was designated Class I by FDA July 18

You may also be interested in...



The Hits Just Keep On Coming: Another Class I Recall For Baxter’s Colleague

Baxter's Colleague infusion pumps are again the subject of a Class I recall

The Hits Just Keep On Coming: Another Class I Recall For Baxter’s Colleague

Baxter's Colleague infusion pumps are again the subject of a Class I recall

Baxter’s Relaunch Of Recalled Infusion Pump Will Add $75 Mil. In ’08 Sales

Baxter expects a mid-year U.S. relaunch of previously recalled Colleague infusion pumps to generate $75 million in sales in 2008

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025039

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel